logo

For the Inventor, By the Inventor

East Lyme, CT, United States of America

Liang H Huang

This inventor holds 16 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 1979-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liang H Huang. Retrieved from https://idiyas.com/inventor/liang-h-huang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16

% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 5

Forward Citations = 107(Granted Patents)


Location History:

  • New York, NY (US) (1995)
  • East Lyme, CT (US) (1979 - 2002)

Company Filing History:

goldMedal16 out of 4,488 
 
Pfizer Corporation
 patents

Years Active: 1979-2002

Loading Chart...
16 patents (USPTO):Explore Patents
1. 6372781 - Compounds for treating gastroduodenal diseases (2002-04-16),
2. 6174710 - Spirolaxine derivatives for treating gastrobuodenal diseases (2001-01-16),
3. 6074855 - Process for preparing spirolaxine and spirolaxine methyl ether (2000-06-13),
4. 5942619 - Quinolone compounds for the treatment of disorders caused by (1999-08-24),
5. 5494820 - Streptomyces braegensis strain and its cultivation in a process for (1996-02-27),
6. 5430055 - Inhibitor of squalene synthase (1995-07-04),
7. 4287182 - Antibiotics produced by a new microbe, Catenuloplanes japonicus (1981-09-01),
8. 4247462 - Ansamycin antibiotic (1981-01-27),
9. 4225674 - Process for producing new ansamycin antibiotic (1980-09-30),
10. 4224314 - Antibiotics produced by species of Nocardia (1980-09-23),
11. 4212944 - Process for producing nocardicin A (1980-07-15),
12. 4195079 - New polycyclic ether antibiotic (1980-03-25),
13. 4169887 - Antibiotics produced by species of actinoplanes (1979-10-02),
14. 4150152 - Polycyclic ether antibiotic produced by a strain of streptomyces (1979-04-17),
15. 4148883 - Antibiotics produced by new species of nocardia (1979-04-10),

Title: Innovations in Gastrointestinal Treatments: The Contributions of Liang H Huang

Introduction

Liang H Huang, an accomplished inventor based in East Lyme, Connecticut, has made significant strides in the field of medicinal compounds, particularly those targeting gastroduodenal diseases. With a remarkable portfolio of 16 patents, Huang stands out as a prominent figure in biopharmaceutical innovation.

Latest Patents

Among Huang's latest contributions are two key patents focusing on compounds for treating gastroduodenal diseases. The first patent describes Spirolaxine, a compound designed to address ailments such as gastric ulcers, duodenal ulcers, and gastric cancer. The innovative formula for Spirolaxine reveals its efficacy in conjunction with H antagonists, colloidal bismuth subcitrate, and various antibiotics. The compounds derived from formula (I), where R can be an alkyl group or specific chemical structures, demonstrate significant therapeutic potential. Additionally, Huang's second patent highlights Spirolaxine derivatives that further extend the treatment options for these serious conditions, showcasing his commitment to advancing medical science.

Career Highlights

Liang H Huang's career has flourished at Pfizer Corporation, a leading pharmaceutical company known for its cutting-edge research and development. His work in developing novel compounds positions him as an influential figure in the quest for effective treatments against chronic gastrointestinal conditions. Huang's research is pivotal in bridging the gap between theoretical science and practical application in pharmacology.

Collaborations

Collaboration is fundamental in the field of innovation, and Huang has effectively worked alongside notable coworkers, including Walter D Celmer and Walter P Cullen. These partnerships have likely enriched his research and contributed to the successful development of groundbreaking medicinal compounds.

Conclusion

In summary, Liang H Huang's contributions to the field of pharmaceutical science, particularly in addressing gastroduodenal diseases, are noteworthy. Through his collaborative efforts and innovative patents, he continues to impact the medical community and enhance treatment options for patients suffering from gastric-related ailments. His work exemplifies the vital role of inventors in the ongoing advancement of healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…